Bone Scintigraphy and SPECT/CT of Bisphosphonate-Induced Osteonecrosis of the Jaw

被引:69
|
作者
Dore, Franca [1 ]
Filippi, Luca [1 ]
Biasotto, Matteo [2 ]
Chiandussi, Silvia [2 ]
Cavalli, Fabio [3 ]
Di Lenarda, Roberto [2 ]
机构
[1] Hosp Maggiore Trieste, Nucl Med Sect, Trieste, Italy
[2] Univ Trieste, Sect Dent Sci, Trieste, Italy
[3] Hosp Maggiore Trieste, Sect Radiodiagnost Imaging, Trieste, Italy
关键词
bone scintigraphy; SPECT/CT; jaw; osteonecrosis; EMISSION-TOMOGRAPHY; SKELETAL LESIONS; RISK-FACTORS; CANCER; CT; ASSOCIATION;
D O I
10.2967/jnumed.107.048785
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Endovenous bisphosphonate therapy seems associated with osteonecrosis of the jaw. The aim of this study was to evaluate the additional diagnostic value of hybrid SPECT/CT in (99m)Tc-methylene diphosphonate 3-phase bone scintigraphy of osteonecrosis of the jaw in bisphosphonate-treated patients. Methods: We studied 15 patients (12 women and 3 men) with extraoral tumors affected by lytic bone metastases and multiple myeloma. All patients were previously treated with intravenous bisphosphonates (zoledronic acid) for 1-3 y, were negative for dental disease at clinical examination, and had suspected osteonecrosis of the jaw. All 15 patients underwent panoramic x-ray orthopantomography, CT or MRI (or both), microbiologic examination, 3-phase bone scintigraphy, and SPECT/CT of the maxillary region. Results: Three-phase bone-scintigraphy showed increased perfusion and an increased blood pool in 9 of 12 and 10 of 12 patients, respectively; at the metabolic phase, SPECT was positive in all patients and showed abnormal hyperactivity in the maxilla of 2 patients, in the mandible of 9 patients, and in both the mandible and the maxilla of 4 patients. Hybrid SPECT/CT was of particular value in 8 of 15 patients, allowing discrimination of the osteonecrotic core from nearby hyperactivity due to viable bone. Whole-body scintigraphy showed remote and multiple metastases in all patients. Orthopantomography showed nonspecific bone rarefaction in all patients but was not able to aid diagnosis of osteonecrosis of the jaw. CT and MRI showed anomalies in all symptomatic patients: CT was helpful in evaluating both cortical and trabecular bone aspects, and MRI was able to detect soft-tissue involvement but not cortical bone destruction. Conclusion: In appropriately selected oncology patients treated with bisphosphonates, an increased uptake of (99m)Tc-methylene diphosphonate in maxillary bones may suggest probable osteonecrosis of the jaw. In such cases, SPECT/CT may be of value in increasing the diagnostic accuracy of bone scanning, providing a precise functional anatomic correlation for the definition of the extent of disease.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 50 条
  • [31] Bisphosphonate-Induced Osteonecrosis of the Jaws, Bone Markers, and a Hypothesized Candidate Gene
    Lehrer, Steven
    Montazem, Andre
    Ramanathan, Lakshmi
    Pessin-Minsley, Melissa
    Pfail, John
    Stock, Richard G.
    Kogan, Rita
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (01) : 159 - 161
  • [32] Tooth alterations in areas of bisphosphonate-induced osteonecrosis
    Moraes, Paulo de Camargo
    Barcellos Silva, Carolina Amalia
    Soares, Andresa Borges
    Passador-Santos, Fabricio
    Pizzigatti Correa, Maria Elvira
    de Araujo, Ney Soares
    de Araujo, Vera Cavalcanti
    [J]. CLINICAL ORAL INVESTIGATIONS, 2015, 19 (02) : 489 - 495
  • [33] A case presentation: Bisphosphonate induced Osteonecrosis of the Jaw in Pagetic Jaw Bone.
    Adams, M.
    Adams, K.
    Freemont, A.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S508 - S508
  • [34] Bisphosphonate-induced osteonecrosis of the jaws: Prevention and management
    Nikitakis, N.
    Kamperos, G.
    Sklavounou-Andrikopoulou, A.
    [J]. ARCHIVES OF HELLENIC MEDICINE, 2009, 26 (05): : 583 - 592
  • [35] Lipopolysaccharide aggravates bisphosphonate-induced osteonecrosis in rats
    Sakaguchi, O.
    Kokuryo, S.
    Tsurushima, H.
    Tanaka, J.
    Habu, M.
    Uehara, M.
    Nishihara, T.
    Tominaga, K.
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2015, 44 (04) : 528 - 534
  • [36] Tooth alterations in areas of bisphosphonate-induced osteonecrosis
    Paulo de Camargo Moraes
    Carolina Amália Barcellos Silva
    Andresa Borges Soares
    Fabrício Passador-Santos
    Maria Elvira Pizzigatti Corrêa
    Ney Soares de Araújo
    Vera Cavalcanti de Araújo
    [J]. Clinical Oral Investigations, 2015, 19 : 489 - 495
  • [37] Imaging findings in bisphosphonate-induced osteonecrosis of the jaws
    Popovic, Katarina Surlan
    Kocar, Miha
    [J]. RADIOLOGY AND ONCOLOGY, 2010, 44 (04) : 215 - 219
  • [38] Bisphosphonate-induced osteonecrosis of the jaw: Incidence and risk factors in patients with breast cancer and gynecological malignancies
    Gall, C.
    Bachmann, C.
    Kraemer, B.
    Solomayer, E.
    Wallwiener, D.
    Fehm, T.
    [J]. ONKOLOGIE, 2008, 31 : 53 - 53
  • [39] Bis-phossy jaws - High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw
    Abu-Id, Mario H.
    Warnke, Patrick H.
    Gottschalk, Joachim
    Springer, Ingo
    Wiltfang, Joerg
    Acil, Yahya
    Russ, Paul A. J.
    Kreusch, Thomas
    [J]. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2008, 36 (02) : 95 - 103
  • [40] Bisphosphonate-Induced Osteonecrosis of the Jaw 32 Months After Interruption of Zoledronate in a Patient With Multiple Myeloma
    Del Conte, Alessandro
    Bernardeschi, Paolo
    La Ferla, Fabio
    Turrisi, Gina
    D'Alessandro, Michelina
    Montagnani, Francesco
    Fiorentini, Giammaria
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (05) : 1179 - 1182